JP2025511869A5 - - Google Patents
Info
- Publication number
- JP2025511869A5 JP2025511869A5 JP2024559427A JP2024559427A JP2025511869A5 JP 2025511869 A5 JP2025511869 A5 JP 2025511869A5 JP 2024559427 A JP2024559427 A JP 2024559427A JP 2024559427 A JP2024559427 A JP 2024559427A JP 2025511869 A5 JP2025511869 A5 JP 2025511869A5
- Authority
- JP
- Japan
- Prior art keywords
- theta
- wavenumbers
- xrpd
- ray powder
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22167057.3 | 2022-04-07 | ||
| EP22167057 | 2022-04-07 | ||
| PCT/EP2023/058906 WO2023194418A1 (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of a macrocyclic peptide antibiotic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511869A JP2025511869A (ja) | 2025-04-16 |
| JP2025511869A5 true JP2025511869A5 (enExample) | 2026-04-13 |
Family
ID=81448543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559427A Pending JP2025511869A (ja) | 2022-04-07 | 2023-04-05 | 大環状ペプチド抗生物質の結晶形態 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4504749A1 (enExample) |
| JP (1) | JP2025511869A (enExample) |
| KR (1) | KR20240169690A (enExample) |
| CN (1) | CN118974073A (enExample) |
| AU (1) | AU2023250008A1 (enExample) |
| CA (1) | CA3255726A1 (enExample) |
| IL (1) | IL315686A (enExample) |
| MX (1) | MX2024012228A (enExample) |
| TW (1) | TW202404991A (enExample) |
| WO (1) | WO2023194418A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026154152A1 (en) * | 2025-01-20 | 2026-07-23 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising an antibiotic macrocyclic peptide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2023
- 2023-04-05 WO PCT/EP2023/058906 patent/WO2023194418A1/en not_active Ceased
- 2023-04-05 JP JP2024559427A patent/JP2025511869A/ja active Pending
- 2023-04-05 KR KR1020247036516A patent/KR20240169690A/ko active Pending
- 2023-04-05 CN CN202380032881.2A patent/CN118974073A/zh active Pending
- 2023-04-05 CA CA3255726A patent/CA3255726A1/en active Pending
- 2023-04-05 AU AU2023250008A patent/AU2023250008A1/en active Pending
- 2023-04-05 EP EP23718634.1A patent/EP4504749A1/en active Pending
- 2023-04-05 IL IL315686A patent/IL315686A/en unknown
- 2023-04-06 TW TW112112829A patent/TW202404991A/zh unknown
-
2024
- 2024-10-03 MX MX2024012228A patent/MX2024012228A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12054501B2 (en) | Compositions and methods for inhibiting arginase activity | |
| JP7367908B2 (ja) | 標的タンパク質分解化合物、その抗腫瘍応用、その中間体および中間体の応用 | |
| RU2007105350A (ru) | 3-(гетероарилокси)-2-алкил-1-азабициклоалкильные производные, как лиганды альфа-7-nachr (никотиновых ацетилхолиновых рецепторов), предназначенные для лечения заболеваний центральной нервной системы | |
| JP2022526438A5 (enExample) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP7475055B2 (ja) | （ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペンタ－１－エン－１－カルボン酸の合成法 | |
| EP2155776A2 (en) | Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof | |
| AU2014297102B2 (en) | Tricyclic benzoxaborole compound, preparation method therefor, and use thereof | |
| WO2009035168A1 (ja) | ４－カルバモイル－５－ヒドロキシ－イミダゾール誘導体のスルホン酸塩化合物 | |
| JP2023553534A5 (enExample) | ||
| CN113891873A (zh) | 新型培比洛芬盐、其制备方法及包含其的药物组合物 | |
| WO2012175002A1 (zh) | 10-甲氧基喜树碱衍生物、制备方法和用途 | |
| JP2024509276A5 (enExample) | ||
| JP6275644B2 (ja) | Ｎ−［２−（｛２−［（２Ｓ）−２−シアノピロリジン−１−イル］−２−オキソエチル｝アミノ）−２−メチルプロピル］−２−メチルピラゾロ［１，５−ａ］ピリミジン−６−カルボキサミドの結晶 | |
| CN101778857A (zh) | 铂(iv)络合物 | |
| JP2010500971A5 (enExample) | ||
| CN104768927B (zh) | (3s,3s’)‑4,4’‑二硫烷二基双(3‑氨基丁烷‑1‑磺酸)合l‑赖氨酸的新的结晶相 | |
| KR20240145001A (ko) | 이사부코나조늄 황산염의 결정질 형태 및 이의 제조 방법 | |
| RU2024129224A (ru) | Кристаллические формы макроциклического пептидного антибиотика | |
| JP7759380B2 (ja) | スルホニル尿素環置換化合物の塩形および結晶形 | |
| WO2014121383A1 (en) | A process for the preparation of rufinamide and intermediates thereof | |
| JPWO2020096041A1 (ja) | （Ｓ）−２−アミノ−３−｛４−［（５−アミノ−２−フェニルベンゾ［ｄ］オキサゾール−７−イル）メトキシ］−３，５−ジクロロフェニル｝プロパン酸・１塩酸塩、その１水和物、およびその結晶とその製造方法 | |
| JP2006520768A (ja) | 金属イオンのキレート化剤として有用な窒素含有多環式誘導体およびそれらの用途 | |
| CN103709177A (zh) | 利福霉素类沃尼妙林杂合抗生素及其制备方法 | |
| US11053254B2 (en) | Crystalline forms of mitomycin C for treatment of cancer |